Caroline Y Kuo Maria I Garcia-Lloret Patricia Slev John F Bohnsack Karin Chen
10.1016/j.jaip.2016.09.028
J Allergy Clin Immunol Pract
2017 Jan-Feb;5(1):198-200.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/28065337/
Aza Compounds / adverse effects Immunosuppressive Agents / adverse effects Lymphopenia / diagnosis Mercaptopurine / adverse effects Prenatal Exposure Delayed Effects / diagnosis Purines / antagonists & inhibitors Receptors, Antigen, T-Cell / genetics Severe Combined Immunodeficiency / diagnosis T-Lymphocytes / physiology
Aza Compounds / adverse effects Immunosuppressive Agents / adverse effects Lymphopenia / diagnosis Mercaptopurine / adverse effects Prenatal Exposure Delayed Effects / diagnosis Purines / antagonists & inhibitors Receptors, Antigen, T-Cell / genetics Severe Combined Immunodeficiency / diagnosis T-Lymphocytes / physiology Case Reports Aza Compounds / therapeutic use Female Humans Immunosuppressive Agents / therapeutic use Infant Infant, Newborn Lymphocyte Count Lymphopenia / genetics Lymphopoiesis / drug effects Male Mercaptopurine / therapeutic use Neonatal Screening Pathology, Molecular Pregnancy United States Aza Compounds Immunosuppressive Agents Purines Receptors, Antigen, T-Cell Mercaptopurine purine
PMC5930011
28065337
Profound T-cell lymphopenia associated with prenatal exposure to purine antagonists detected by TREC newborn screening
2017